...
首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: Focus on the role of androgen receptor CAG polymorphism
【24h】

Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: Focus on the role of androgen receptor CAG polymorphism

机译:睾丸激素替代疗法对男性术后性腺功能低下性腺功能减退症的骨代谢的影响:专注于雄激素受体CAG多态性的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction and aim: The relationship between androgen receptor (AR) CAG polymorphism and bone metabolism is highly controversial. We, therefore, aimed to evaluate the independent role of AR CAG repeat polymorphism on bone metabolism improvement induced by testosterone replacement therapy (TRT) in male post-surgical hypogonadotropic hypogonadism, a condition frequently associated with hypopituitarism and in which the effects of TRT have to be distinguished from those resulting from concomitant administration of pituitary function replacing hormones. Methods: 12 men affected by post-surgical hypogonadotropic hypogonadism [mean duration of hypogonadism 8.3 ± 2.05 (SD) months] were retrospectively assessed before and after TRT (from 74 to 84 weeks after the beginning of therapy). The following measures were studied: parameters of bone metabolism [serum markers and bone mineral density (BMD)], pituitary dependent hormones and genetic analysis (AR CAG repeat number). Results: Total testosterone, estradiol, free T4 (FT4) and insulin-like growth factor-1 (IGF-1) increased between the two phases, while follicle stimulating hormone (FSH) decreased. While serum markers did not vary significantly between the two phases, BMD improved slightly but significantly in all the studied sites. The number of CAG triplets correlated negatively and significantly with all the variations (Δ-) of BMDs. Conversely, Δ-testosterone correlated positively and significantly with all studied Δ-BMDs, while Δ-FSH, Δ-estradiol, Δ-FT4, and Δ-IGF-1 did not correlate significantly with any of the Δ-BMDs. Multiple linear regression analysis, after correction for Δ-testosterone, showed that CAG repeat length was negatively and significantly associated with Δ-BMD of all measured sites. Conclusions: Our data suggest that, in post-surgical male hypogonadotropic hypogonadism, shorter AR CAG tract is independently associated with greater TRT-induced improvement of BMD.
机译:引言和目的:雄激素受体(CA)CAG基因多态性与骨代谢之间的关系存在争议。因此,我们旨在评估AR CAG重复多态性对男性手术后性腺功能低下性腺功能减退症(一种经常与垂体机能减退相关的病症)的睾丸激素替代疗法(TRT)诱导的骨代谢改善的独立作用。区别于那些同时给予垂体功能替代激素的人。方法:回顾性分析在TRT前后(治疗开始后74至84周)回顾性评估的12名男性术后性腺功能减退性腺功能减退[平均性腺功能减退持续时间8.3±2.05(SD)月]。研究了以下措施:骨代谢参数[血清标志物和骨矿物质密度(BMD)],垂体依赖性激素和遗传分析(AR CAG重复数)。结果:两个阶段之间总睾丸激素,雌二醇,游离T4(FT4)和胰岛素样生长因子-1(IGF-1)升高,而促卵泡激素(FSH)降低。虽然两个阶段之间的血清标志物没有显着变化,但BMD在所有研究部位均略有改善,但显着改善。 CAG三联体的数量与BMD的所有变异(Δ-)呈负相关且显着相关。相反,Δ-睾丸激素与所有研究的Δ-BMD呈正相关,而Δ-FSH,Δ-雌二醇,Δ-FT4和Δ-IGF-1与任何Δ-BMD均不显着相关。校正了Δ-睾丸激素后,多元线性回归分析显示,CAG重复长度与所有测量部位的Δ-BMD呈负相关,并显着相关。结论:我们的数据表明,在男性术后性腺功能减退性腺功能减退症中,较短的AR CAG通道与更大的TRT诱导的BMD改善独立相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号